I started my Tremfya (guselkumab) journey on Monday, August 21, 2017. On December 11, after three injections (week 0, 4, 12), I reached that interim endpoint of 16 weeks. Here I evaluate my experience so far with Tremfya, including efficacy, side effects, and how I'm feeling overall. The "verdicts" in this post reflect a moment in time, and certainly are not final.
I wrote this article for the National Psoriasis Foundation as an update to my Treat to Target experience earlier this year. The editor decided to take excerpts from below as a postscript and republish as An ongoing experiment with Treat to Target. See the postscript for a brief week 13 with Tremfya update.
I’m a dreamer. Psoriasis treatments, however, dash my hopes more times I care to remember. After five weeks on the new biologic medication Tremfya (guselkumab) do I dare to dream that it just might clear my skin of nasty psoriasis lesions? What is my biggest fear taking a new biologic for the first time in years?
I'm entering the time when I expect to see more results from Otezla at two months. I started this new-to-me medication on May 15th for my psoriasis, and hopefully eczema. Unfortunately, instead of improving, I feel more and more inflammation on my skin than I have in a long time. Should I keep going?
Today I found out that insurance denied my dermatologist’s prescription for Otezla (apremilast). With so many days passing before hearing I assumed the scrip ran into issues. I was right.